Navigation Links
FDA-Approved Sculptra@ Now Offers by Orange County Dermatologist Dr. Cheryl Effron
Date:11/10/2009

Board Certified Dermatologist and Regional Sculptra@ trainer Dr Cheryl Effron of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable prices.

(PRWEB) November 10, 2009 -- Board Certified Dermatologist and Regional Sculptra@ trainer Dr Cheryl Effron of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable prices.

Sculptra Aesthetic@ is a facial injectable treatment which volumizes shallow to deep facial wrinkles and folds by stimulating the growth of human collagen (which we tend to lose with age). An injectable form of poly-L-lactic-acid (PLLA), it has been used for some years for medical purposes, but has only recently been approved by the FDA for cosmetic purposes.

The effects of Sculptra Aesthetic@ are gradual and less likely than more immediate treatments to leave patients looking as though they’ve “had work done.” In addition to being gradual, the effects can last for over 2 years. Being a simple injective, Sculptra Aesthetic@ is minimally invasive, completely biocompatible, and requires no downtime. Furthermore, because a local anesthetic is already applied, treatment can be combined with facial correctors (ie. Juvaderm, Resthalyne, Radiesse, etc). In addition to this, Sculptra Aesthetic@ can be purchased at an affordable price (9 CCs for $895).

Dr. Effron was trained in Europe (where injectible poly-L-lactic-acid has been used for years) for this procedure. Also, Dr. Effron is a Board Certified Trainer for Plastic Surgeons and Dermatologists for Sculptra. Dr. Effron is also a regional trainer for this procedure, and was one of the first dermatologists in the US to obtain certification in its administration. This procedure should only be done by a Board Certified Trainer.

Cosmetic Dermatology of Orange County offices are conveniently located in Huntington Beach (a short drive from the 405 FWY) and Anaheim Hills (a short drive from the 91 FWY).

# # #

Read the full story at http://www.prweb.com/releases/2009/11/prweb3169674.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
2. Upsher-Smith Launches New Website for Divigel(R), a Bioidentical and FDA-Approved Hormone Therapy for Moderate to Severe Hot Flashes, Including Night Sweats, Associated with Menopause
3. Introducing anuleaf AD, a New FDA-Approved Hemorrhoid Treatment
4. MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
5. Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
6. Grow Back Eyelashes - Orange County Plastic Surgeon Now Helps Patients Grow Longer, Fuller Darker Eyelashes With FDA-Approved Prescription Lash Treatment, Latisse
7. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
8. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
9. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
10. IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
11. Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon Kleyne ... declared on her radio program in November 2016 the need to educate people about ... leaders in corporate America, they are trying to take advantage of successful algorithms and ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies and ... scam operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “Tomorrow Trump ... Donald Trump bringing greatness back to the presidency and to America. “Tomorrow Trump Goes ... to do as much as she can for this country. , Nancy attributes her ...
(Date:12/7/2016)... Soquel, Caloifornia (PRWEB) , ... December 07, 2016 ... ... to present the fifth annual Business Architecture Innovation Summit in Reston, VA on ... the world who will share a range of experiences from a cross-section of ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to a new market research report "Clinical Decision ... Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - ... reach USD 1,519.2 Million by 2021 from USD 856.3 Million in 2016, ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... Today, Stock-Callers.com presents four Biotech equities for review, ... Pharmaceuticals Inc. (NASDAQ: ANTH ), ProNAi Therapeutics Inc. ... AVXS ). From its peak in July 2015, the ... level equal to what it saw at the start of ... year, it has still out-performed other market sectors, beating the ...
(Date:12/6/2016)... Dec. 6, 2016  Alopexx Oncology, LLC announced data ... antibody fusion protein (immunocytokine) composed of interleukin-2 and a ... target on B cells as Rituxan and maintains the ... is also involved in tumor targeting, engagement of the ... The results of the study (abstract #95954) were presented ...
Breaking Medicine Technology: